Hundreds more children suffering from rare muscle-wasting condition spinal muscular atrophy (SMA) are set to gain access to "life-changing" treatments following their approval for widespread use across the NHS.
One mother, whose son benefited from an early access scheme for one of these therapies, attested that it had "fundamentally changed the course of his life".
